The US is communicating regularly with India in bilateral and multilateral channels to discuss the supply of Covid-19 vaccines and inquire about its timeline for restarting vaccine exports. “Vaccinating as much of the developing world, as quickly as possible, is in America’s vital interest, because the uncontrolled spread of the virus inevitably produces more dangerous variants,” an Axios report said. |
The United States has been pushing India to restart vaccine exports as it looks to stem the global spread of the Covid pandemic.
The US is communicating regularly with India in bilateral and multilateral channels to discuss the supply of Covid-19 vaccines and inquire about its timeline for restarting vaccine exports, a senior Biden administration official told Reuters.
The supply of Covid vaccines will also be one of the key topics of discussion during the first in-person Quad leadership meeting in US on September 24. Quad is a multilateral alliance of US, India, Australia and Japan.
During their virtual meeting in March this year, the Quad leaders had agreed to work closely on boosting Covid-19 vaccine supply.
However, the initiative was stalled after India was struck by the deadly second wave of the virus.
Since then, India’s vaccine exports took a major hit as the country sought to prioritise immunisation of its population of over 1.3 billion people.
According to Axios, the Biden administration is now looking to push Modi to renew vaccine supply to the world through the global Covax initiative since it wants to mitigate the international spread of the virus.
“Vaccinating as much of the developing world, as quickly as possible, is in America’s vital interest, because the uncontrolled spread of the virus inevitably produces more dangerous variants,” the Axios report said.
“Washington was staying in close touch with India and other Quad partners about the vaccine partnership, and any factors that may affect this project or global vaccine supply, but those discussions were not tied to a specific summit or engagement,” the US official said.
The official noted that Washington had diverted its own supply of raw materials for vaccine production to India in April, given its urgent needs, and global vaccine supply remained a key bottleneck to ending the pandemic.
“We commend India for being one of the largest manufacturers for safe and effective COVID-19 vaccines globally, and we note that COVAX and the world rely heavily on India’s contributions,” the official said. “It’s important for the United States to engage all our allies and partners on these matters so we can take the necessary actions to end this pandemic together.“
However, while US is pushing India to kickstart its vaccine exports, it had stalled its own vaccine exports for months to prioritise shots for its population under the “America First” policy.
Targeted drug delivery revolutionises treatment by focusing medications on specific tissues, reducing the impact on healthy cells. Scientists enhance this precision with carriers like microspheres and nanoparticles, controlling release and absorption. Microspheres, made from biodegradable proteins or polymers, sustain drug release, making them ideal for targeted therapies, especially in oncology. Beyond drug delivery, microspheres open new possibilities across industries—from next-gen coatings to thermal insulation. With tailored sizes, shapes, and materials, they drive advancements in pharmaceuticals, advanced materials, and more.
The U.S. Food and Drug Administration (FDA) has proposed a new rule to require standardized testing of talc-containing cosmetics for asbestos. The FDA noted that this move aims to protect consumers from potential harm posed by asbestos, a known carcinogen linked to serious illnesses such as lung and ovarian cancers.
As one of the most significant holidays in China, Chinese New Year (CNY) profoundly impacts global shipping, logistics, and supply chains. Scheduled to begin on January 29, 2025, this festive period lasts up to two weeks, with many factories, ports, and businesses shutting down or operating with limited staff. Understanding the implications of CNY on your supply chain is critical to avoid disruptions and ensure seamless operations.
Disruptions in the Red Sea, Suez Canal, and Panama Canal have driven up shipping costs, sending shockwaves through the global economy.
It was truly heartwarming to see so many clients and associates visiting our stand, even as late as at the end of the show, sharing drinks and engaging in conversations.
Ocean freight rates on key global container routes have fallen again. Despite the upcoming Golden Week in China, which usually drives demand, the situation this year is slightly different, and the expected rate increase may not happen.
Highly potent active pharmaceutical ingredients (HPAPIs) are at the dangers of cross-contamination with other product forefront of pharmaceutical manufacturing. They are particularly common in targeted therapies and personalized medicines. This is primarily due to their potent therapeutic effects at low dosage forms.
The floating traffic jams off ports. The multiplying costs of moving freight. The resulting shortages of goods. All of this had seemed like an unpleasant memory confined to the COVID-19 pandemic. But no such luck!
An ocean container capacity crunch has hit global trade just as peak shipping season starts, with freight spot rates up some 30% over the past few weeks and heading higher.